DE69129750D1 - Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung - Google Patents

Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung

Info

Publication number
DE69129750D1
DE69129750D1 DE69129750T DE69129750T DE69129750D1 DE 69129750 D1 DE69129750 D1 DE 69129750D1 DE 69129750 T DE69129750 T DE 69129750T DE 69129750 T DE69129750 T DE 69129750T DE 69129750 D1 DE69129750 D1 DE 69129750D1
Authority
DE
Germany
Prior art keywords
new medical
indolder
derivative
certain
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69129750T
Other languages
English (en)
Other versions
DE69129750T2 (de
Inventor
Alison Jane Pilgrim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE69129750D1 publication Critical patent/DE69129750D1/de
Application granted granted Critical
Publication of DE69129750T2 publication Critical patent/DE69129750T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
DE69129750T 1990-10-12 1991-10-11 Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung Expired - Fee Related DE69129750T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909022250A GB9022250D0 (en) 1990-10-12 1990-10-12 Medicaments
PCT/GB1991/001768 WO1992006688A1 (en) 1990-10-12 1991-10-11 New medical use for a certain indole derivative and pharmaceutical composition containing it

Publications (2)

Publication Number Publication Date
DE69129750D1 true DE69129750D1 (de) 1998-08-13
DE69129750T2 DE69129750T2 (de) 1998-11-12

Family

ID=10683660

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69129750T Expired - Fee Related DE69129750T2 (de) 1990-10-12 1991-10-11 Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung

Country Status (16)

Country Link
US (1) US5376672A (de)
EP (1) EP0552205B1 (de)
JP (1) JP3159263B2 (de)
KR (1) KR0178762B1 (de)
AT (1) ATE168006T1 (de)
AU (1) AU660153B2 (de)
CA (1) CA2093527A1 (de)
DE (1) DE69129750T2 (de)
DK (1) DK0552205T3 (de)
ES (1) ES2118090T3 (de)
GB (1) GB9022250D0 (de)
IE (1) IE913580A1 (de)
IL (1) IL99715A (de)
TW (1) TW212756B (de)
WO (1) WO1992006688A1 (de)
ZA (1) ZA918117B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0737074B1 (de) * 1993-12-28 2001-08-01 Allergan Sales, Inc. Botulinumtoxine zur behandlung von hyperhydrosis
MX9703988A (es) * 1994-12-12 1998-02-28 Omeros Med Sys Inc SOLUCIaN Y MÉTODO DE IRRIGACIaN PARA LA INHIBICIaN DEL DOLOR, LA INFLAMACIaN Y ES ESPASMO.
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
EP1765300A2 (de) * 2004-06-10 2007-03-28 Duramed Pharmaceuticals, Inc. Formulierungen von sumatriptan zur absorption durch biologische membranen, und herstellungs- und anwendungsverfahren
CA2665841C (en) 2006-10-09 2016-04-05 Charleston Laboratories, Inc. Pharmaceutical compositions
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
US8304179B2 (en) * 2009-05-11 2012-11-06 Taiwan Semiconductor Manufacturing Company, Ltd. Method for manufacturing a semiconductor device using a modified photosensitive layer
US20100287502A1 (en) * 2009-05-11 2010-11-11 Olympus Imaging Corp. Image search device and image search method
CA2767576C (en) 2009-07-08 2020-03-10 Charleston Laboratories Inc. Pharmaceutical compositions comprising an antiemetic and an opioid analgesic
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GR79215B (de) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative

Also Published As

Publication number Publication date
ES2118090T3 (es) 1998-09-16
TW212756B (de) 1993-09-11
ATE168006T1 (de) 1998-07-15
EP0552205B1 (de) 1998-07-08
DE69129750T2 (de) 1998-11-12
US5376672A (en) 1994-12-27
WO1992006688A1 (en) 1992-04-30
KR0178762B1 (ko) 1999-03-20
AU8642291A (en) 1992-05-20
IE913580A1 (en) 1992-04-22
AU660153B2 (en) 1995-06-15
JPH06501935A (ja) 1994-03-03
EP0552205A1 (de) 1993-07-28
CA2093527A1 (en) 1992-04-13
IL99715A0 (en) 1992-08-18
JP3159263B2 (ja) 2001-04-23
GB9022250D0 (en) 1990-11-28
ZA918117B (en) 1992-08-26
DK0552205T3 (da) 1999-04-19
IL99715A (en) 1996-01-19

Similar Documents

Publication Publication Date Title
TR199902253T2 (xx) �n g�z odac���nda farmas�tik maddelerin kontroll� sal�n�m�.
ATE231719T1 (de) Neue pharmazeutische formulierungen
DE69721766D1 (de) Neue arzneiformulierung
IT1202558B (it) Protesi interna per la sostituzione di una parte del corpo umano particolarmente nelle operazioni vascolari
DE69129750D1 (de) Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung
DK0423297T3 (da) Indretning til brug i den kirurgiske terapi ved brud på eller svækkelse af kapslen for drejemusklerne i et menneskes skulderled
CO4340681A1 (es) Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero
ID28003A (id) Turunan-turunan adamantana
DE69400435D1 (de) Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen
DE69226649D1 (de) Analoge des menschlichen Interleukin-8.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
SE9402880D0 (sv) New peptide derivatives
GEP20053423B (en) Method of Inhibiting Amyloid Protein Aggregation and Method for Imaging of Amyloid Deposits
HUT76796A (en) Use of 2,4-diamino pyrimidine 3-oxide or salts thereof for preparing pharmaceutical composition for treating collagen maturation and structruring disorders
IS4619A (is) Ný læknisfræðileg notkun
SE9201425D0 (sv) Method and means for preventing constriction of the pupil in the eye
DE69616591D1 (de) Pharmazeutische zusammensetzung, die muirapuama und pflanzenwürmer enthaelt
DE59306983D1 (de) Arzneimittel zur verhinderung der toleranzentwicklung während der behandlung mit benzodiazepin-rezeptor-bindenden wirkstoffen
NO952912D0 (no) En ny osteoblastisk proliferativ faktor
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
FI960026A (fi) Värejä, joissa on tetra-aminopyrimidiiniä ja suoravärjäysaineita

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee